HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NEOTERIC COSMETICS FIRST QUARTER SALES REACH $7.2 MIL.

This article was originally published in The Rose Sheet

Executive Summary

NEOTERIC COSMETICS FIRST QUARTER SALES REACH $7.2 MIL., up from $1.7 mil. in the first three months of 1993, parent company Scott's Liquid Gold discloses in a registration statement for a bonds offering filed recently with the Securities and Exchange Commission. Neoteric markets Alpha Hydrox skin care products. The firm notes that it "believes that the sales increase in Alpha Hydrox is due to several factors: effective and extensive advertising of the cosmetics line, competitive pricing, the addition of five new products in May 1993, and the efficacy of the Company's cosmetics products." Neoteric added Foaming Face Wash, Toner-Astringent, Oil-Free Facial Formula, Extra-Rich All Body Lotion and Daily Hydrating Eye Gel in May, and is extending the line with another five products this month ("The Rose Sheet" May 30, p. 3). The firm advertises Alpha Hydrox in print and TV ads. The items in the line are priced at under $10 each, suggested retail.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel